5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE TO SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales: Eleftheriou, P., Sharif, J., Kesse-Adu, R., Filian-Gloor, M., Agrawal, A., Barcelos, G., Telfer, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112590/
http://dx.doi.org/10.1097/01.HS9.0000928248.83702.ec
Descripción
Sumario:

Ejemplares similares